Clinical Trials Browser

alisporivir × Lymphoid × Clear all

NCT01860326 2016-04-28

Evaluate the Pharmacokinetics, Safety, and Tolerability of Alisporivir in Subjects With Hepatic Impairment Compared to Healthy Subjects

Phase 1 Completed

Lymphoma, Follicular, Hepatic Insufficiency